Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 75

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 75
---
 or
grant licenses on terms unfavorable to us.

Insiders will continue to have substantial influence over us after this offering, which could limit your ability to affect the outcome of key transactions, including a change of control.

After this offering, our
directors, officers, holders of more than 5% of our outstanding shares and their respective affiliates will beneficially own shares representing
approximately 59.2% of our outstanding Ordinary Shares, assuming no exercise of the Representative’s option to purchase additional
shares and additional warrants without giving effect to any shares that certain of these holders may make through our directed share
program or otherwise. As a result, these shareholders, if they act together, will be able to influence our management and affairs and
all matters requiring shareholder approval, including the election of directors and approval of significant corporate transactions. This
concentration of ownership may have the effect of delaying or preventing a change in control of our company and might affect the market
price of our Ordinary Shares.

The JOBS Act, allows us to postpone the date by which we must comply with some of the laws and regulations intended to protect investors and to reduce the amount of information we provide in our reports filed with the SEC, which could undermine investor confidence in our company and adversely affect the market price of our ADSs or our Ordinary Shares.

For so long as we remain
an “emerging growth company” as defined in the JOBS Act, we intend to take advantage of certain exemptions from various requirements
that are applicable to public companies that are not “emerging growth companies” including:

| ● | the provisions of the Sarbanes-Oxley                                                                                                    
 Act requiring that our independent registered public accounting firm provide an attestation report on the effectiveness of our internal 
 control over financial reporting;                                                                                                       |

| ● | Section 107 of the JOBS                                                                                                       
 Act, which provides that an “emerging growth company” can take advantage of the extended transition period provided in        
 Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. This means that an “emerging 
 growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private 
 companies; and                                                                                                                |

| ● | any rules that may be adopted                                                                                                    
 by the Public Company Accounting Oversight Board requiring mandatory audit firm rotation or a supplement to the auditor’s report 
 on the financial statements.                                                                                                     |

We intend to take advantage
of these exemptions until we are no longer an “emerging